Combining Clinical Judgment With Guidelines for the Management of Type 2 Diabetes: Overall Standards of Comprehensive Care

References

• . American Diabetes Association (ADA). Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2013;36:1033–1046
   PubMed Web of Science ®Google Scholar
• . Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr. 2010;8:29
   PubMed Web of Science ®Google Scholar
• . Saydah SH, Loria CM, Eberhardt MS, Brancati FL. Subclinical states of glucose intolerance and risk of death in the U.S. Diabetes Care. 2001;24(3):447–453
   PubMed Web of Science ®Google Scholar
• . Centers for Disease Control and Prevention (CDC). Diabetes successes and opportunites for population-based prevention and control. 2011. http://www.cdc.gov/chronicdisease/resources/publications/AAG/ddt.htm. Accessed July 10, 2013
   Google Scholar
• . Booth AO, Lowis C, Dean M, Hunter SJ, McKinley MC. Diet and physical activity in the self-management of type 2 diabetes: barriers and facilitators identified by patients and health professionals. Prim Health Care Res Dev. 2013;14(3):293–306
   PubMed Web of Science ®Google Scholar
• . American Diabetes Assocation (ADA). Standards of medical care in diabetes—2014. Diabetes Care. 2014;37 Suppl 1:S14–S80
   Web of Science ®Google Scholar
• . Garber AJ, Abrahamson MJ, Barzilay JI, . AACE comprehensive diabetes management algorithm 2013. Endocr Pract. 2013;19(2):327–336
   PubMed Web of Science ®Google Scholar
• . Handelsman Y, Mechanick JI, Blonde L, . American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan. Endocr Pract. 2011;17( Suppl 2):1–53
   PubMed Web of Science ®Google Scholar
• . Inzucchi SE, Bergenstal RM, Buse JB, . Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012;35(6):1364–1379
   PubMed Web of Science ®Google Scholar
• . Nathan DM, Buse JB, Davidson MB, . Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009;32(1):193–203
   PubMed Web of Science ®Google Scholar
• . Qaseem A, Humphrey LL, Sweet DE, . Oral pharmacologic treatment of type 2 diabetes mellitus: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2012;156(3):218–231
   PubMed Web of Science ®Google Scholar
• . Rodbard HW, Jellinger PS, Davidson JA, . Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control. Endocr Pract. 2009;15(6):540–559
   PubMed Web of Science ®Google Scholar
• . Department of Veterans Affairs/Department of Defense (VA/DoD).Clinical Practice Guideline for the Management of Diabetes Mellitus. 2010
   Google Scholar
• . Matthews DR, Inzucchi SE, and Position Statement Writing Group. ADA/EASD position statement of the treatment of type 2 diabetes: Reply to Rodbard HW and Jellinger PS [letter], Scheen AJ [letter] and Ceriello A, Gallo M, Gentile S et al [letter]. Diabetologia. 2012;55(10):2856–2857
   PubMed Web of Science ®Google Scholar
• . Muhlhauser I. From authority recommendations to fact-sheets—a future for guidelines. Diabetologia. 2010;53(11):2285–2288
   PubMed Web of Science ®Google Scholar
• . Rodbard HW, Jellinger PS. The American Association of Clinical Endocrinologists/American College of Endocrinology (AACE/ACE) algorithm for managing glycaemia in patients with type 2 diabetes mellitus: comparison with the ADA/EASD algorithm. Diabetologia. 2010;53(11):2458–2460
   PubMed Web of Science ®Google Scholar
• . Rodbard HW, Jellinger PS. A critique of the 2012 ADA/EASD position statement. Diabetologia. 2012;55(10):2850–2852
   PubMed Web of Science ®Google Scholar
• . Nathan DM, Buse JB, Davidson MB, . Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2006;29(8):1963–1972
   PubMed Web of Science ®Google Scholar
• . Groff MW. How to incorporate clinical experience into evidence-based medicine. Clin Neurosurg. 2009;56:54–56
   PubMedGoogle Scholar
• . Citrome L. Evidence-based medicine: it's not just about the evidence. Int J Clin Pract. 2011;65(6):634–635
   PubMed Web of Science ®Google Scholar
• . Duggal R, Menkes DB. Evidence-based medicine in practice. Int J Clin Pract. 2011;65(6):639–644
   PubMed Web of Science ®Google Scholar
• . Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn't. BMJ. 1996;312(7023):71–72
   PubMed Web of Science ®Google Scholar
• . Seidu S, Khunti K. Non-adherence to diabetes guidelines in primary care—the enemy of evidence-based practice. Diabetes Res Clin Pract. 2012;95(3):301–302
   PubMed Web of Science ®Google Scholar
• . Francke AL, Smit MC, de Veer AJ, Mistiaen P. Factors influencing the implementation of clinical guidelines for health care professionals: a systematic meta-review. BMC Med Inform Decis Mak. 2008;8:38
   PubMed Web of Science ®Google Scholar
• . Larme AC, Pugh JA. Attitudes of primary care providers toward diabetes: barriers to guideline implementation. Diabetes Care. 1998;21(9):1391–1396
   PubMed Web of Science ®Google Scholar
• . Ratsep A, Kalda R, Oja I, Lember M. Family doctors' knowledge and self-reported care of type 2 diabetes patients in comparison to the clinical practice guideline: cross-sectional study. BMC Fam Pract. 2006;7:36
   PubMedGoogle Scholar
• . Lew WY, DeMaria AN. The divergence between clinical guidelines and practice. J Am Coll Cardiol. 2013;61(1):41–43
   PubMed Web of Science ®Google Scholar
• . Shekelle P, Woolf S, Grimshaw JM, Schunemann HJ, Eccles MP. Developing clinical practice guidelines: reviewing, reporting, and publishing guidelines; updating guidelines; and the emerging issues of enhancing guideline implementability and accounting for comorbid conditions in guideline development. Implement Sci. 2012;7:62
   PubMed Web of Science ®Google Scholar
• . Anderson RM, Funnell MM, Butler PM, . Patient empowerment. Results of a randomized controlled trial. Diabetes Care. 1995;18(7):943–949
   PubMed Web of Science ®Google Scholar
• . Evert AB, Boucher JL, Cypress M, . Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care. 2013;36(11):3821–3842
   PubMed Web of Science ®Google Scholar
• . Pi-Sunyer FX. National Heart, Lung, and Blood Institute Northern America for the Study of Obesity. Practical Guide Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Bethesda, MD: National Institutes of Health, 2000
   Google Scholar
• . Pan A, Sun Q, Bernstein AM, . Changes in red meat consumption and subsequent risk of type 2 diabetes mellitus: three cohorts of US men and women. JAMA Intern Med. 2013;173(14):1328–1335
   PubMed Web of Science ®Google Scholar
• . Petersen KS, Torpy DJ, Chapman IM, . Food label education does not reduce sodium intake in people with type 2 diabetes mellitus. A randomised controlled trial. Appetite. 2013;68:147–151
   PubMed Web of Science ®Google Scholar
• . Jackness C, Karmally W, Febres G, . Very low calorie diet mimics the early beneficial effect of Roux-en-Y gastric bypass on insulin sensitivity and beta-cell function in type 2 diabetic patients. Diabetes. 2013;62:3027–3032
   PubMed Web of Science ®Google Scholar
• . Norris SL, Zhang X, Avenell A, . Long-term non-pharmacologic weight loss interventions for adults with type 2 diabetes. Cochrane Database Syst Rev. 2005;(2):CD004095
   Google Scholar
• . Colberg SR. Physical activity: the forgotten tool for type 2 diabetes management. Front Endocrinol (Lausanne). 2012;3:70
   PubMedGoogle Scholar
• . Boulé NG, Haddad E, Kenny GP, Wells GA, Sigal RJ. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA. 2001;286(10):1218–1227
   PubMed Web of Science ®Google Scholar
• . Brownell K. The LEARN Program for Weight Management. Dallas: American Health Publishing Company, 2004
   Google Scholar
• . Allison DB, Gadde KM, Garvey WT, . Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP). Obesity (Silver Spring). 2012;20(2):330–342
   PubMed Web of Science ®Google Scholar
• . Centers for Disease Control and Prevention (CDC). National Diabetes Prevention Program. http://www.cdc.gov/diabetes/prevention/about.htm. Accessed July 16, 2013
   Google Scholar
• . Monnier L and Colette C. Fasting glucose and postprandial glycemia: which is the best target for improving outcomes? The Apollo and 4-T Trials. Expert Opin Pharmacother. 2008;9(16):2857–2865
   PubMed Web of Science ®Google Scholar
• . Boutati EI and Raptis SA. Self-monitoring of blood glucose as part of the integral care of type 2 diabetes. Diabetes Care. 2009;32( Suppl 2): S205–S210
   Web of Science ®Google Scholar
• . Ceriello A, Barkai L, Christiansen JS, . Diabetes as a case of chronic disease management with a personalized approach: the role of a structured feedback loop. Diabetes Res Clin Pract. 2012;98(1):5–10
   PubMed Web of Science ®Google Scholar
• . Ceriello A, Gallo M, Gentile S, . To what extent is the new position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) “personalised”? Diabetologia. 2012;55(10):2853–2855
   PubMed Web of Science ®Google Scholar
• . Zgibor JC, Simmons D. Barriers to blood glucose monitoring in a multiethnic community. Diabetes Care. 2002;25(10):1772–1777
   PubMed Web of Science ®Google Scholar
• . Raz I, Riddle MC, Rosenstock J, . Personalized management of hyperglycemia in type 2 diabetes: reflections from a Diabetes Care Editors' Expert Forum. Diabetes Care. 2013;36(6):1779–1788
   PubMed Web of Science ®Google Scholar
• . Tsapas A, Matthews DR. N of 1 trials in diabetes: making individual therapeutic decisions. Diabetologia. 2008;51(6):921–925
   PubMed Web of Science ®Google Scholar
• . Virkamäki A, Saltevo J. Finnish Current Care Guideline for Diabetes: interactive approach to improve individualised treatment. Diabetologia. 2011;54(5):1264–1265
   PubMed Web of Science ®Google Scholar
• . Italian Association of Medical Diabetologists (AMD). Personalisation of therapy in type 2 diabetes. http://www.aemmedi.it/algoritmi_en_2013/intro-english.html. Accessed July 16, 2013
   Google Scholar
• . Wilkinson MJ, Nathan AG, Huang ES. Personalized decision support in type 2 diabetes mellitus: current evidence and future directions. Curr Diab Rep. 2013;13(2):205–212
   PubMed Web of Science ®Google Scholar
• . van Leeuwen N, Swen JJ, Guchelaar HJ, Hart LM. The role of pharmacogenetics in drug disposition and response of oral glucose-lowering drugs. Clin Pharmacokinet. 2013;52:833–854
   PubMed Web of Science ®Google Scholar